tradingkey.logo

Cosmos Health Inc

COSM
查看详细走势图
0.487USD
-0.020-3.96%
收盘 12/19, 16:00美东报价延迟15分钟
15.52M总市值
亏损市盈率 TTM

Cosmos Health Inc

0.487
-0.020-3.96%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.96%

5天

+10.31%

1月

-21.92%

6月

+12.79%

今年开始到现在

-27.22%

1年

-16.47%

查看详细走势图

TradingKey Cosmos Health Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Cosmos Health Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名124/158位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价3.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Cosmos Health Inc评分

相关信息

行业排名
124 / 158
全市场排名
404 / 4582
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
3.000
目标均价
+511.87%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Cosmos Health Inc亮点

亮点风险
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
业绩增长期
公司处于发展阶段,最新年度总收入54.43M美元
估值低估
公司最新PE估值-0.64,处于3年历史低位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值235.74K
活跃度增加
近期活跃度增加,过去20天平均换手率0.15

Cosmos Health Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Cosmos Health Inc简介

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
公司代码COSM
公司Cosmos Health Inc
CEOSiokas (Grigorios)
网址https://www.cosmosholdingsinc.com/

常见问题

Cosmos Health Inc(COSM)的当前股价是多少?

Cosmos Health Inc(COSM)的当前股价是 0.487。

Cosmos Health Inc的股票代码是什么?

Cosmos Health Inc的股票代码是COSM。

Cosmos Health Inc股票的52周最高点是多少?

Cosmos Health Inc股票的52周最高点是1.320。

Cosmos Health Inc股票的52周最低点是多少?

Cosmos Health Inc股票的52周最低点是0.280。

Cosmos Health Inc的市值是多少?

Cosmos Health Inc的市值是15.52M。

Cosmos Health Inc的净利润是多少?

Cosmos Health Inc的净利润为-22.38M。

现在Cosmos Health Inc(COSM)的股票是买入、持有还是卖出?

根据分析师评级,Cosmos Health Inc(COSM)的总体评级为--,目标价格为3.000。

Cosmos Health Inc(COSM)股票的每股收益(EPS TTM)是多少

Cosmos Health Inc(COSM)股票的每股收益(EPS TTM)是-0.760。
KeyAI